Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates breast cancer cell metastatic behaviors through inhibition of plasminogen activation and extracellular proteolysis

Lignende værker

• Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates fibrin-dependent plasmin generation on thrombin-activated platelets
  af: Ni, Ran, et al.
  Udgivet: (2020)
• Kinetics of Activated Thrombin-activatable Fibrinolysis Inhibitor (TAFIa)-catalyzed Cleavage of C-terminal Lysine Residues of Fibrin Degradation Products and Removal of Plasminogen-binding Sites
  af: Foley, Jonathan H., et al.
  Udgivet: (2011)
• Isolation, Co-Crystallization and Structure-Based Characterization of Anabaenopeptins as Highly Potent Inhibitors of Activated Thrombin Activatable Fibrinolysis Inhibitor (TAFIa)
  af: Schreuder, Herman, et al.
  Udgivet: (2016)
• Tissue-type plasminogen activator transgenic rats for evaluating inhibitors of the activated form of thrombin-activatable fibrinolysis inhibitor
  af: Ito, Yusuke, et al.
  Udgivet: (2018)
• Thrombin activatable fibrinolysis inhibitor activation and bleeding in haemophilia A
  af: Foley, J. H., et al.
  Udgivet: (2011)